P01.01 LIBRETTO-432: A Placebo-Controlled Phase 3 Study of Adjuvant Selpercatinib in Stage IB-IIIA RET Fusion-Positive NSCLC
Year: 2021
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: J. Goldman, B. Besse, Y. Wu, J.C. Yang, L. Paz-Ares, A. Drilon, M. Johnson, M. Xia, B.H. Chao, M. Tsuboi
Institutions: University of California, Los Angeles, Université Paris-Saclay, Institut Gustave Roussy, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, National Taiwan University, National Taiwan University Hospital, Universidad Complutense de Madrid, Hospital Universitario 12 De Octubre, Memorial Sloan Kettering Cancer Center, Eli Lilly (United States), National Cancer Center Hospital East
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3205763214